Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of the Heart01:07

Overview of the Heart

12.4K
The heart, a muscular organ located in the chest, functions as the body's pump, circulating blood through the vascular system. It has four chambers: two atria on top and two ventricles below. The right atrium receives deoxygenated blood from the body and passes it to the right ventricle, which pumps it to the lungs for oxygenation. The left atrium receives oxygenated blood from the lungs and transfers it to the left ventricle, which pumps it to the rest of the body.
The heart's structure...
12.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

657
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
657
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same author

Federated multi-cloud task scheduling with load balancing using multi-objective NSGA-II and reinforcement learning.

Scientific reports·2026
Same author

PlantCLR: contrastive self-supervised pretraining for generalizable plant disease detection.

Scientific reports·2026
Same author

Correction: Almuhaya et al. ZBMG-LoRa: A Novel Zone-Based Multi-Gateway Approach Towards Scalable LoRaWANs for Internet of Things. <i>Sensors</i> 2025, <i>25</i>, 5457.

Sensors (Basel, Switzerland)·2026
Same author

Hybrid AI Intrusion Detection: Balancing Accuracy and Efficiency.

Sensors (Basel, Switzerland)·2025
Same author

Methodological Advances in Transcriptomics and Metabolomics for Assessing Crop Stress Resilience.

Physiologia plantarum·2025

Related Experiment Video

Updated: Jan 7, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.2K

Ensemble learning approach with explainable AI for improved heart disease prediction.

Ayomide Adekoya1, Faisal Saeed1, Wad Ghaban2

  • 1Department of Computer Science, Birmingham City University, Birmingham, United Kingdom.

Frontiers in Pharmacology
|December 29, 2025
PubMed
Summary

The Interpretable Ensemble Learning Framework (IELF) enhances heart disease prediction by combining Explainable Boosting Machines (EBM) and XGBoost. This approach improves model interpretability and clinical reliability for cardiovascular risk assessment.

Keywords:
XGBoostcardiovascular diseaseensembleensemble learningexplainable AIheart disease

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 7, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Artificial Intelligence
  • Machine Learning
  • Cardiovascular Medicine

Background:

  • Heart disease is a major global health concern, driving the need for accurate and interpretable predictive models.
  • Existing models often lack transparency, hindering clinical trust and adoption.
  • Explainable AI (XAI) techniques are crucial for understanding model decisions in healthcare.

Purpose of the Study:

  • To introduce the Interpretable Ensemble Learning Framework (IELF) for enhanced cardiovascular risk prediction.
  • To integrate Explainable Boosting Machines (EBM) with XGBoost, SHAP, and LIME for improved local interpretability.
  • To establish a trustworthy benchmark for translational AI in cardiology.

Main Methods:

  • IELF was evaluated on the Cleveland (n=303) and Framingham (n=4,240) heart disease datasets.
  • Rigorous validation included 5-fold cross-validation, held-out test sets, calibration, and subgroup analyses.
  • Explanation stability was assessed using Kendall's τ and Overlap@10 metrics.

Main Results:

  • IELF demonstrated robust discrimination, achieving an AUC of 0.899 on Cleveland and 0.696 on Framingham.
  • The framework significantly improved recall, F1-score, and AUC compared to EBM on the Framingham dataset (p < 0.05).
  • IELF provided transparent feature rankings aligned with known cardiovascular risk factors and stable explanations.

Conclusions:

  • IELF is the first framework to combine EBM and XGBoost with SHAP and LIME under strict validation protocols.
  • Despite potentially lower headline accuracies than some models, IELF prioritizes reproducibility, interpretability, and clinical reliability.
  • IELF serves as a reliable benchmark for AI in cardiovascular risk prediction, balancing performance with transparency.